Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Razoxane × 90 days × Clear all

Sponsor

Conditions

Ganglioneuroblastoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 PRETEXT I Hepatoblastoma 1 Neuroblastoma 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Burkitt Lymphoma 1

Interventions

Magnetic Resonance Spectroscopy 6 X-Rays 4 Specimen Handling 4 Phantoms, Imaging 4 Biopsy 4 Nuclear Medicine Department, Hospital 3 tazemetostat 2 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 cabozantinib 2 Radiotherapy 2 Lomustine 2 LY3023414 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 regorafenib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lutetium Lu 177 dotatate 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡